C-X-C chemokine receptors type 4 (CXCR4) have been reported to overexpress in most cancers, including glioma (Gatti et al., 2013; Virgintino et al., 2013; Nazari et al., 2017). This evidence concerns the gene CXCR4 and central nervous system cancer.